What is AbbVie Inc. worth?
With the base-case assumptions below, a discounted cash flow model on AbbVie Inc.'s reported free cash flow gives $160.20 per share. The share price was $264.34 on September 25, 2026, 65% above that value.
Inputs from the filings
Three sets of assumptions
| Case | Growth yrs 1-5 | Discount rate | Value per share | Value vs price |
|---|---|---|---|---|
| Bear | 1.0% | 10.0% | $84.79 | -68% |
| Base | 6.0% | 9.0% | $160.20 | -39% |
| Bull | 11.0% | 8.0% | $300.99 | +14% |
Sensitivity: base case value per share
| 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | |
|---|---|---|---|---|---|
| 7.0% | $214.50 | $231.07 | $251.33 | $276.65 | $309.20 |
| 8.0% | $173.98 | $184.73 | $197.43 | $212.68 | $231.30 |
| 9.0% | $144.38 | $151.72 | $160.20 | $170.09 | $181.79 |
| 10.0% | $121.82 | $127.04 | $132.97 | $139.73 | $147.54 |
| 11.0% | $104.08 | $107.91 | $112.19 | $117.01 | $122.47 |
Where the presets come from
Base: years 1 to 5 grow at AbbVie Inc.'s revenue growth rate over the last 5 fiscal years (6.0% a year), held between -5% and 15%. Years 6 to 10 grow halfway between that and the long-run rate of 2.5%. Future cash is discounted at 9% a year.
Bear: 5 points less growth, 2% long-run growth, 10% discount rate. Bull: 5 points more growth (at most 25%), 3% long-run growth, 8% discount rate.
Value per share = (present value of 10 years of free cash flow + present value of everything after + cash - debt) / diluted shares.
This is a model run on assumptions, not a recommendation or a price target. Small changes in the discount rate or growth move the result a lot, as the table above shows. Change them yourself in the calculator.
Adjust the assumptions
Move the sliders for growth, long-run growth and discount rate, or switch to average free cash flow, and see the value per share change.
Adjust the assumptions